These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 16127378

  • 1. Alteration in spectral properties on ligand binding reveals flexibility in monoamine oxidase.
    Ramsay RR, Jones TZ, Hynson RM.
    Med Sci Monit; 2005 Sep; 11(9):SR15-20. PubMed ID: 16127378
    [Abstract] [Full Text] [Related]

  • 2. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.
    Vintém AP, Price NT, Silverman RB, Ramsay RR.
    Bioorg Med Chem; 2005 May 16; 13(10):3487-95. PubMed ID: 15848762
    [Abstract] [Full Text] [Related]

  • 3. Functional role of the "aromatic cage" in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins.
    Li M, Binda C, Mattevi A, Edmondson DE.
    Biochemistry; 2006 Apr 18; 45(15):4775-84. PubMed ID: 16605246
    [Abstract] [Full Text] [Related]

  • 4. Orientation of oxazolidinones in the active site of monoamine oxidase.
    Jones TZ, Fleming P, Eyermann CJ, Gravestock MB, Ramsay RR.
    Biochem Pharmacol; 2005 Aug 01; 70(3):407-16. PubMed ID: 15950194
    [Abstract] [Full Text] [Related]

  • 5. [Mechanistic study of monoamine oxidase: significance for MAO A and MAO B in situ].
    Ramsay RR.
    Vopr Med Khim; 1997 Aug 01; 43(6):457-70. PubMed ID: 9503563
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N, Simşek OO, Ercan A, Yelekçi K, Sahin ZS, Işik S, Uçar G, Bilgin AA.
    Bioorg Med Chem; 2009 Sep 15; 17(18):6761-72. PubMed ID: 19682910
    [Abstract] [Full Text] [Related]

  • 7. Conformational changes in monoamine oxidase A in response to ligand binding or reduction.
    Hynson RM, Kelly SM, Price NC, Ramsay RR.
    Biochim Biophys Acta; 2004 Apr 07; 1672(1):60-6. PubMed ID: 15056494
    [Abstract] [Full Text] [Related]

  • 8. Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines.
    Wu HF, Chen K, Shih JC.
    Mol Pharmacol; 1993 Jun 07; 43(6):888-93. PubMed ID: 8316221
    [Abstract] [Full Text] [Related]

  • 9. Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B.
    Binda C, Wang J, Li M, Hubalek F, Mattevi A, Edmondson DE.
    Biochemistry; 2008 May 20; 47(20):5616-25. PubMed ID: 18426226
    [Abstract] [Full Text] [Related]

  • 10. Modeling of substrate-binding region of the active site of monoamine oxidase A.
    Veselovsky AV, Medvedev AE, Tikhonova OV, Skvortsov VS, Ivanov AS.
    Biochemistry (Mosc); 2000 Aug 20; 65(8):910-6. PubMed ID: 11002183
    [Abstract] [Full Text] [Related]

  • 11. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
    McDonald GR, Olivieri A, Ramsay RR, Holt A.
    Pharmacol Res; 2010 Dec 20; 62(6):475-88. PubMed ID: 20832472
    [Abstract] [Full Text] [Related]

  • 12. A second redox group in monoamine oxidase: its role in catalysis and inhibition.
    Ramsay RR, Sablin SO.
    Neurobiology (Bp); 1999 Dec 20; 7(2):205-12. PubMed ID: 10591053
    [Abstract] [Full Text] [Related]

  • 13. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A.
    Jones TZ, Giurato L, Guccione S, Ramsay RR.
    FEBS J; 2007 Mar 20; 274(6):1567-75. PubMed ID: 17480205
    [Abstract] [Full Text] [Related]

  • 14. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
    Limon-Boulez I, Tesson F, Gargalidis-Moudanos C, Parini A.
    J Pharmacol Exp Ther; 1996 Feb 20; 276(2):359-64. PubMed ID: 8632297
    [Abstract] [Full Text] [Related]

  • 15. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
    Gallardo-Godoy A, Fierro A, McLean TH, Castillo M, Cassels BK, Reyes-Parada M, Nichols DE.
    J Med Chem; 2005 Apr 07; 48(7):2407-19. PubMed ID: 15801832
    [Abstract] [Full Text] [Related]

  • 16. Observation of two different chromophores in the resting state of monoamine oxidase B by fluorescence spectroscopy.
    Woo JC, Silverman RB.
    Biochem Biophys Res Commun; 1994 Aug 15; 202(3):1574-8. PubMed ID: 8060341
    [Abstract] [Full Text] [Related]

  • 17. [Oxidative modification of monoamine oxidase].
    Medvedev AE, Tipton KF.
    Vopr Med Khim; 1997 Aug 15; 43(6):471-81. PubMed ID: 9503564
    [Abstract] [Full Text] [Related]

  • 18. Arginine-42 and threonine-45 are required for FAD incorporation and catalytic activity in human monoamine oxidase B.
    Kirksey TJ, Kwan SW, Abell CW.
    Biochemistry; 1998 Sep 01; 37(35):12360-6. PubMed ID: 9724550
    [Abstract] [Full Text] [Related]

  • 19. Partial conversion of Hansenula polymorpha amine oxidase into a "plant" amine oxidase: implications for copper chemistry and mechanism.
    Welford RW, Lam A, Mirica LM, Klinman JP.
    Biochemistry; 2007 Sep 25; 46(38):10817-27. PubMed ID: 17760423
    [Abstract] [Full Text] [Related]

  • 20. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders.
    Binda C, Newton-Vinson P, Hubálek F, Edmondson DE, Mattevi A.
    Nat Struct Biol; 2002 Jan 25; 9(1):22-6. PubMed ID: 11753429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.